BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 16434315)

  • 1. Frequencies and characterization of cytogenetically unrelated clones in various hematologic malignancies: seven years of experiences in a single institution.
    Han JY; Theil KS; Hoeltge G
    Cancer Genet Cytogenet; 2006 Jan; 164(2):128-32. PubMed ID: 16434315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytogenetically unrelated clones in hematological neoplasms.
    Heim S; Mitelman F
    Leukemia; 1989 Jan; 3(1):6-8. PubMed ID: 2909809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytogenetic polyclonality in hematologic malignancies.
    Johansson B; Billström R; Broberg K; Fioretos T; Nilsson PG; Ahlgren T; Malm C; Samuelsson BO; Mitelman F
    Genes Chromosomes Cancer; 1999 Mar; 24(3):222-9. PubMed ID: 10451702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Consecutive chromosomal studies in patients with myelodysplastic syndrome (MDS). Czechoslovak MDS Cooperative Group.
    Michalova K; Musilova J; Zemanova Z
    Ann Genet; 1991; 34(3-4):212-8. PubMed ID: 1809229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of del(20q) in patients with hematological malignancies.
    Brezinová J; Zemanová Z; Ransdorfová S; Sindelárová L; Sisková M; Neuwirtová R; Cermák J; Michalová K
    Cancer Genet Cytogenet; 2005 Jul; 160(2):188-92. PubMed ID: 15993278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Karyotypically unrelated clones in acute leukemias and myelodysplastic syndromes.
    Kobayashi H; Kaneko Y; Maseki N; Sakurai M
    Cancer Genet Cytogenet; 1990 Jul; 47(2):171-8. PubMed ID: 2357693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytogenetic biclonality in malignant hematologic disorders.
    Furuya T; Morgan R; Sandberg AA
    Cancer Genet Cytogenet; 1992 Aug; 62(1):25-8. PubMed ID: 1521230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cytogenetic studies in hematological diseases. Analysis of 185 cases].
    Porto B; Mota A; Coutinho J; Justiça B; Malheiro MI
    Sangre (Barc); 1993 Apr; 38(2):103-14. PubMed ID: 8516724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytogenetics of secondary myelodysplasia (sMDS) and acute nonlymphocytic leukemia (sANLL).
    Johansson B; Mertens F; Heim S; Kristoffersson U; Mitelman F
    Eur J Haematol; 1991 Jul; 47(1):17-27. PubMed ID: 1868912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unrelated clonal chromosome abnormalities in myelodysplastic syndromes and acute myeloid leukemias.
    Han JY; Kim KH; Kwon HC; Kim JS; Kim HJ; Lee YH
    Cancer Genet Cytogenet; 2002 Jan; 132(2):156-8. PubMed ID: 11850080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cytogenetic study of exudates secondary to hematologic processes].
    Bello MJ; Rey JA; Moreno S; Martínez Castro P; Benítez J
    Sangre (Barc); 1988 Jun; 33(3):165-70. PubMed ID: 3175812
    [No Abstract]   [Full Text] [Related]  

  • 12. Cytogenetic findings in adult greek myelodysplastic syndrome patients: predominance of single trisomy 8.
    Panani AD
    In Vivo; 2006; 20(1):115-8. PubMed ID: 16433038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chromosomal aberrations in bone marrow mesenchymal stroma cells from patients with myelodysplastic syndrome and acute myeloblastic leukemia.
    Blau O; Hofmann WK; Baldus CD; Thiel G; Serbent V; Schümann E; Thiel E; Blau IW
    Exp Hematol; 2007 Feb; 35(2):221-9. PubMed ID: 17258071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural aberrations of chromosome 7 revealed by a combination of molecular cytogenetic techniques in myeloid malignancies.
    Brezinová J; Zemanová Z; Ransdorfová S; Pavlistová L; Babická L; Housková L; Melichercíková J; Sisková M; Cermák J; Michalová K
    Cancer Genet Cytogenet; 2007 Feb; 173(1):10-6. PubMed ID: 17284364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multicolor fluorescence in situ hybridization characterization of cytogenetically polyclonal hematologic malignancies.
    Davidsson J; Paulsson K; Johansson B
    Cancer Genet Cytogenet; 2005 Dec; 163(2):180-3. PubMed ID: 16337865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Genetic origin of malignant hematopoiesis well defined].
    Bernell P; Jacobsson B
    Lakartidningen; 1998 Nov; 95(48):5493-4, 5497-8. PubMed ID: 9854375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular cytogenetic profiling of complex karyotypes in primary myelodysplastic syndromes and acute myeloid leukemia.
    Trost D; Hildebrandt B; Beier M; Müller N; Germing U; Royer-Pokora B
    Cancer Genet Cytogenet; 2006 Feb; 165(1):51-63. PubMed ID: 16490597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytogenetic deletion maps of hematologic neoplasms: circumstantial evidence for tumor suppressor loci.
    Johansson B; Mertens F; Mitelman F
    Genes Chromosomes Cancer; 1993 Dec; 8(4):205-18. PubMed ID: 7512363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple unrelated clones in myelodysplastic syndrome and in acute myeloid leukemia.
    Musilová J; Michalová K; Zemanová Z; Brezinová J
    Cancer Genet Cytogenet; 1996 Jun; 88(2):141-3. PubMed ID: 8640723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FISH studies identify the i(20q-) anomaly as a der(20)del(20)(q11q13)idic(20)(p11).
    Li T; Xue Y; Wu Y; Pan J
    Genes Chromosomes Cancer; 2006 Jun; 45(6):536-9. PubMed ID: 16506189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.